The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
Frequently asked questions
What is the Invesco Dynamic Biotechnology & Genome ETF (PBE) expense ratio?
The Invesco Dynamic Biotechnology & Genome ETF funds expense ratio is 0.58%.
What is Invesco Dynamic Biotechnology & Genome ETF (PBE) current stock price?
As of the latest data, Invesco Dynamic Biotechnology & Genome ETF stock price is $99.21, with a previous close of $98.72. Invesco Dynamic Biotechnology & Genome ETF gained $0.49 in the last trading session, representing a 0.5% increase.
Does Invesco Dynamic Biotechnology & Genome ETF (PBE) pay dividends?
Yes. Invesco Dynamic Biotechnology & Genome ETF pays quarterly dividends with an annualized yield of 1.34% and an estimated annual payout of $1.33 per share.
